Some studies hint towards the impact of EGFR inhibition on the induction of CIITA expression in non-small cell lung cancer [45]; however, studies are warranted that will validate these findings in CRC and to exploit them for better patient treatment. The gene discussed is EGFR; the disease is colorectal carcinoma.